<DOC>
	<DOCNO>NCT00900016</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue blood patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study assess fibroblast activity patient localize pancreatic cancer undergo surgery .</brief_summary>
	<brief_title>Studying Fibroblast Activity Patients With Localized Pancreatic Cancer Undergoing Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - To assess degree fibroblast activation protein ( FAP ) enzymatic activity tumor site patient localized pancreatic cancer . Secondary - To explore correlation tumor stromal FAP enzymatic activity stromal α_2-antiplasmin level . - To explore correlation tumor FAP enzymatic activity plasma dipeptidyl peptidase plasma α_2-antiplasmin convert enzyme activity potential surrogate . OUTLINE : Patients undergo fine-needle aspiration tumor suspect mass baseline . Tumor sample analyze IHC fibroblast activation protein ( FAP ) expression , immunocapture assay ex vivo FAP enzymatic activity , western analysis FAP concentration . Blood sample collect weekly analyze dipeptidyl peptidase activity ELISA α_2-antiplasmin convert enzyme .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven adenocarcinoma pancreas pancreatic mass suspicious pancreatic cancer Localized disease Scheduled undergo resection exploration pancreatic tumor PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>adenocarcinoma pancreas</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>stage I pancreatic cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
</DOC>